ChromoGenics has received a complementary order from Ticon where we are adding, among other things, also façade solar panels. The result will be huge energy savings in the property and it also shows the path to the future.
By combining ChromoGenics technology in ConverLight® Paragon with colored solar panels for façades from KameleonSolar the Ticon project will do a retrofit project that saves more than 85% of the energy use in the building without affecting the architecture. ConverLight Paragon blocks up to 90% of the heat transmission into the building. It insulates as good as a wall and still maintains 100% access to daylight and outside view.
By this project ChromoGenics are creating solutions where we in the future will be able to build properties where the Façade actually is generating energy. ChromoGenics technology combined with the solution from KameleonSolar are opening very interesting possibilities for buildings of tomorrow.
“The Ticon project has a very exciting solution where our technology is combined with another technology like the façade solar panels from KameleonSolar. Our vision is that by utilizing the ConverLight technology in combination with for example solar panels we will be able to create so called plus façades that actually generates energy. This is in line with our goal to be the innovation leader in the business”, says CEO Jerker Lundgren.
Jerker Lundgren, CEO
Lars Ericsson, CFO and Head of Communications
Tel: +46 (0)18 430 0430
Certified Adviser: G&W Fondkommission, e-mail: email@example.com, tel.: +46 (0) 8 503 000 50
Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.
ChromoGenics offers dynamic glass with controllable heat- and light transmission and static glass with world leading performance. The company’s unique technology ConverLight® provides sustainable solar control for increased indoor comfort and energy efficiency. ConverLight also contributes to Green Building certifications. In 2016 the company started commercial sales to real estate projects in Scandinavia.
ChromoGenics is located in Uppsala, Sweden, and the technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser.